Exact Sciences' total revenues reach $14.8M in Q1 2016, FDA clears EndoGastric Solutions' EsophyX Z device & more — 8 GI company key notes

Here are eight recent news updates on key gastroenterology and endoscopy companies.

Exact Sciences reported total revenues of $14.8 million for the first quarter of 2016, compared to $4.3 million for the same period last year.

GI Windows will soon debut its Incision-less Anastomosis System.

PENTAX Medical launched the OPTIVISTA EPK-i7010 Video Processor in the European, Middle Eastern and African markets.

EndoStim completed a $25 million Series D financing round.

The FDA granted 510(k) clearance for EndoGastric Solutions' EsophyX Z device.

Synthetic Biologics, a clinical stage company developing therapeutics to protect the gut microbiome, named Isaac J. Bright, MD, vice president, corporate development.

EndoGastric Solutions will present new data on the company's Transoral Incisionless Fundoplication procedure for the treatment of gastroesophageal reflux disease at the Digestive Disease Week 2016 Annual Meeting, from May 21 to 24, in San Diego.

TiGenix NV will present the week 24 positive results from its Phase III ADMIRE-CD pivotal study of Cx601 at the 2016 Digestive Disease Week in San Diego on May 24.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast